Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 1457983-28-6
2. G-749
3. 8-bromo-2-((1-methylpiperidin-4-yl)amino)-4-((4-phenoxyphenyl)amino)pyrido[4,3-d]pyrimidin-5(6h)-one
4. 8-bromo-2-[(1-methylpiperidin-4-yl)amino]-4-(4-phenoxyanilino)-6h-pyrido[4,3-d]pyrimidin-5-one
5. Unii-b06w426b66
6. 8-bromo-2-((1-methylpiperidin-4-yl)amino)-4-((4-phenoxyphenyl)amino)pyrido(4,3-d)pyrimidin-5(6h)-one
7. 8-bromo-2-((1-methylpiperidin-4-yl)amino)-4-(4-phenoxyanilino)-6h-pyrido(4,3-d)pyrimidin-5-one
8. Refchem:131866
9. G-801
10. G749
11. Pyrido[4,3-d]pyrimidin-5(6h)-one, 8-bromo-2-[(1-methyl-4-piperidinyl)amino]-4-[(4-phenoxyphenyl)amino]-
12. B06w426b66
13. 8-bromo-2-[(1-methyl-4-piperidinyl)amino]-4-[(4-phenoxyphenyl)amino]pyrido[4,3-d]pyrimidin-5(6h)-one
14. C25h25brn6o2
15. Mfcd28167815
16. Denfivontinib [inn]
17. Gtpl8108
18. Orb1305257
19. Chembl4544478
20. Schembl15265027
21. Schembl30471308
22. Bdbm756196
23. Glxc-90053
24. Ex-a1074
25. Bdbm50422751
26. S7545
27. Us12350272, Compound 226
28. Akos026750566
29. Ccg-269863
30. Cs-3343
31. Ebc-220145
32. Ncgc00386412-04
33. Ac-33000
34. Bs-15433
35. Da-33613
36. Hy-12333
37. G-749?
38. Q27077763
39. 38-bromo-11-methyl-6-oxa-2,4-diaza-3(2,4)-pyrido[4,3-d]pyrimidina-1(4)-piperidina-5(1,4),7(1)-dibenzenaheptaphan-35(36h)-one
40. 8-bromo-2-[(1-methyl-4-piperidyl)amino]-4-(4-phenoxyanilino)-6h-pyrido[4,3-d]pyrimidin-5-one
41. 8-bromo-2-[(1-methylpiperidin-4-yl)amino]-4-[(4-phenoxyphenyl)amino]-5h,6h-pyrido[4,3-d]pyrimidin-5-one
| Molecular Weight | 521.4 g/mol |
|---|---|
| Molecular Formula | C25H25BrN6O2 |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 91.4 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 716 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
25
PharmaCompass offers a list of Denfivontinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Denfivontinib manufacturer or Denfivontinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Denfivontinib manufacturer or Denfivontinib supplier.
A Denfivontinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Denfivontinib, including repackagers and relabelers. The FDA regulates Denfivontinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Denfivontinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Denfivontinib supplier is an individual or a company that provides Denfivontinib active pharmaceutical ingredient (API) or Denfivontinib finished formulations upon request. The Denfivontinib suppliers may include Denfivontinib API manufacturers, exporters, distributors and traders.
Denfivontinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Denfivontinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Denfivontinib GMP manufacturer or Denfivontinib GMP API supplier for your needs.
A Denfivontinib CoA (Certificate of Analysis) is a formal document that attests to Denfivontinib's compliance with Denfivontinib specifications and serves as a tool for batch-level quality control.
Denfivontinib CoA mostly includes findings from lab analyses of a specific batch. For each Denfivontinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Denfivontinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Denfivontinib EP), Denfivontinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Denfivontinib USP).